Intravenous immunoglobulin and autoimmune thrombocytopenic purpura: 22 Years on

Vox Sanguinis

Volumn 86, Issue 1, 2004, Pages 8-14

  Bierling, Philippe ^a   Godeau, B ^a  

^a HENRI MONDOR HOSPITAL   (France)

Author keywords

Autoimmune thrombocytopenic purpura; Intravenous immunoglobulin

Indexed keywords

DEXAMETHASONE; IMMUNOGLOBULIN; METHYLPREDNISOLONE; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISOLONE; PREDNISONE; RHESUS D ANTIBODY;

ACUTE HEART INFARCTION; ACUTE KIDNEY FAILURE; ANAPHYLAXIS; ARTHRALGIA; AUTOIMMUNE DISEASE; BACKACHE; CHILL; CLINICAL TRIAL; DOSE RESPONSE; DRUG CHOICE; DRUG COST; DRUG EFFICACY; DRUG FORMULATION; DRUG INDICATION; DRUG INFUSION; DRUG MECHANISM; DRUG MEGADOSE; DRUG TOLERABILITY; FATIGUE; HEADACHE; HEPATITIS C; HIGH RISK PATIENT; HUMAN; HYPERTENSION; INFECTION RISK; MENINGITIS; MYALGIA; PATIENT MONITORING; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; STROKE; THROMBOCYTE COUNT; THROMBOCYTOPENIC PURPURA; TREATMENT INDICATION; VIRUS TRANSMISSION;

HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; PLATELET COUNT; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; TIME FACTORS; TREATMENT OUTCOME;

EID: 1042276767     PISSN: 00429007     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0042-9007.2004.00391.x     Document Type: Review

References (35)

1. Imbach P, Barandunm S, d'Apuzzo V, Baumgartner C, Hirt A, Morell A, Rossi E, Schoni M, West M, Wagner HP: High dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood. Lancet 1981; 1:1228-1230
2. Intravenous Immunoglobulin: Prevention and Treatment of Disease. NIH Consensus Development Conference Statement, 8, no. 5. May 21-23 1990. Bethesda, MD, USA, Office of Medical Applications of Research, National Institutes of Health, 1990
3. Decocq G, De Cagny B, Andrejak M, Desablens B: Insuffisance rénale aiguë secondaire à l'administration d'immunoglobulines intraveineuses: quatre observations et revue de la littérature. Therapie 1996; 51:516-526
4. Caress JB, Cartwright MS, Donofrio PD, Peacock JE: The clinical features of 16 cases of stroke associated with administration of IV Ig. Neurology 2003; 60:1822-1824
5. Elkayam O, Paran D, Milo R, Davidovitz Y, Almoznino-Sarafian D, Zeltser D, Yaron M, Caspi D: Acute myocardial infarction associated with high dose intravenous immunoglobulin infusion for autoimmune disorders: a study of four cases. Ann Rheum Dis 2000; 59:7780
6. Ryan ME, Webster ML, Statler JD: Adverse effects of intravenous immunoglobulin therapy. Clin Pediatr 1996; 35:23-31
7. Kazatchkine MD, Kaveri SV: Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin. N Engl J Med 2001; 10:747-755
8. Pawlotsky JM, Blerling P, Bouvier M, Desforges L, Duval J, Dhumeaux D: Chronic hepatitis C after high dose intravenous immunoglobulin. Transfusion 1994; 34:86-87
9. Lefrere JJ, Loiseau P, Martinot-Peignoux M, Mariotti M, Ravera N, Thauvin M, Marcellin P, Janot C: Infection by hepatitis C virus through contaminated intravenous immune globulin: results of a prospective national inquiry in France. Transfusion 1996; 63:394-397
10. Bierling P, Oksenhendler E, Habibi B, Karianakis G, Desaint C, Brossard Y, Duedari N: Anti-Rhesus antibodies as treatment for HIV-related immune thrombocytopenia. Ann Int Med 1987; 106:773-774
11. Kimberly RP, Salmon JE, Bussel JB, Crow MK, Hilgartner MW: Modulation of mononuclear phagocyte function by intravenous gammaglobulin. J Immunol 1984; 132:745-750
12. Fehr J, Hofmann V, Kappeler U: Transient reversal of thrombocytopenia in idiopathic purpura by high-dose intravenous gammaglobulin. N Engl J Med 1982; 306:1254-1258
13. Clarkson SB, Bussel JB, Kimberly RP, Valinsky JE, Nachman RL, Unkeless JC: Treatment of refractory immune thrombocytopenic purpura with an anti-Fcy gamma-receptor antibody. N Engl J Med 1986; 314:1236-1239
14. Soubrane C, Tourani JM, Andrieu JM, Visonneau S, Beldjord K, Israel-Biet D, Mouawad R, Bussel J, Weil M, Khayat D: Biologic response to anti-CD16 monoclonal antibody therapy in a human immunodeficiency virus-related immune thrombocytopenic purpura patient. Blood 1993; 81:15-19
15. Debre M, Bonnet MC, Fridman WH, Carosella E, Philippe N, Reinert P, Vilmer E, Kaplan C, Teillaud JL, Griscelli C: Infusion of Fcy fragments for treatment of children with acute immune thrombocytopenic purpura. Lancet 1993; 342:945-949
16. Samuelsson A, Towers TL, Ravetch JV: Anti-inflammatory activity of IV Ig mediated through the inhibitory Fc receptor. Science 2001; 291:484-486
17. Kurlander RJ, Rosse WF: Efficacy of a 2-day schedule for administering intravenous immunoglobulin (IV Ig) in treating adults with ITP. Blood 1986; 68:112A
18. Uchino H, Yasunaga K, Akasuka JI: A cooperative trial of high dose intravenous immunoglobulin therapy in 177 cases of idiopathic thrombocytopenic purpura. Thromb Haemost 1984; 51:182-185
19. Godeau B, Lesage S, Divine M, Wirquin V, Farcet JP, Bierling P: Treatment of adult chronic autoimmune thrombocytopenic purpura with repeated high dose intravenous immunoglobulin. Blood 1993; 82:1415-1421
20. Godeau B, Caulier MT, Decuypere L, Bierling P: Intravenous immunoglobulin for adults with autoimmune thrombocytopenic purpura: results of a randomised trial comparing 0.5 and 1 g/kg bw. Br J Haematol 1999; 107:716-719
21. Blanchette V, Imbach P, Andrew M, Adams M, McMillan J, Wang E, Milner R, Ali K, Barnard D, Bernstein M: Randomized trial of intravenous immunoglobulin G, intravenous anti-D and oral prednisone in childhood acute immune thrombocytopenic purpura. Lancet 1994; 334:703-707
22. Jacobs P, Wood L, Novitzky N: Intravenous gammaglobulin has no advantages over oral corticosteroids as primary therapy for adults with immune thrombocytopenia: a prospective randomised clinical trial. Am J Med 1994; 97:55-59
23. Alpdogan O, Budak-Alpdogan T, Ratip S, Firatli-Tugular T, Tanverdi S, Karti S, Bayik M, Akoglu T: Efficacy of high-dose methylprednisone as a first-line therapy in adult patients with idiopathic thrombocytopenic purpura. Br J Haematol 1998; 103: 1061-1063
24. Andersen JC: Response of resistant idiopathic thrombocytopenic purpura to pulsed high dose dexamethasone therapy. N Engl J Med 1994; 330:1560-1564
25. Cheng Y, Wong RSM, Soo Y, Chui CH, Lau FY, Chan N, Wong WS, Cheng G: Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone. N Engl J Med 2003; 349:831-836
26. Caulier MT, Rose C, Roussel MT, Huart C, Bauters F, Fenaux P: Pulsed high-dose dexamethasone in refractory chronic idiopathic thrombocytopenic purpura: a report on 10 cases. Br J Haematol 1995; 91:477-479
27. Godeau B, Oksenhendler E, Castaigne S, Deconninck E, Wechsler B, Bierling P: High-dose dexamethasone therapy for resistant autoimmune thrombocytopenia. Am J Hematol 1996; 51:334
28. Von Dem Borne AEG, Vos JJE, Pegels JG, Thomas LLM, Von Der Lelie H: High-dose methylprednisolone or high-dose intravenous immunoglobulin for autoimmune thrombocytopenia. Br Med J 1988; 296:249-250
29. Godeau B, Zini JM, Schaeffer A, Bierling P: High dose methylprednisolone is an alternative treatment for adults with autoimmune thrombocytopenic purpura refractory to intravenous immunoglobulins and oral corticosteroids. Am J Hematol 1995; 48:282-284
30. Godeau B, Chevret S, Varet B, Lefrere F, Zini JM, Bassompierre F, Cheze S, Legouffe E, Hulin C, Grange MJ, Fain O, Bierling P: Intravenous immunoglobulin or high-dose methylprednisolone, with or without subsequent oral prednisone, for adults with untreated severe autoimmune thrombocytopenic purpura: a randomized multicentre trial. Lancet 2002; 359:23-29
31. Ancona KG, Parker RI, Atlas MP, Prakash D: Randomized trial of high-dose methylprednisone versus intravenous immunoglobulin for the treatment of acute idiopathic thrombocytopenic purpura in children. J Pediatr Hematol Oncol 2002; 24:540-544
32. Newman GC, Novoa MV, Fodero EM, Lesser ML, Woloski BM, Bussel JB: A dose of 75 gg/kg/d of IV anti-D increases the platelet count more rapidly and for a longer period of time than 50 gg/kg/d in adults with immune thrombocytopenic purpura. Br J Haematol 2001; 112:1076-1078
33. Bussel JB, Kimberly RP, Inman RD, Schulman I, Cunningham-Rundles C, Cheung N, Smithwick EM, O'Malley J, Barandun S, Hilgartner MW: Intravenous gammaglobulin treatment of chronic idiopathic thrombocytopenic purpura. Blood 1983; 62:480-486
34. Bussel JB, Pham LC, Aledort L, Nachman R: Maintenance treatment of adults with chronic refractory immune thrombocytopenic purpura using repeated intravenous infusions of gammaglobulin. Blood 1988; 72:121-127
35. Bierling P, Godeau B: Antibodies in the therapy of autoimmune thrombocytopenia. Practical recommendations. Biodrugs 1997; 7:99-106